Remove Drug Pricing Remove Insurance Coverage and Processing Remove Vaccines
article thumbnail

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. MAXSHOT.PL via Shutterstock. A decision by the FDA is expected in H1 2026.

article thumbnail

DoH and Children’s National Hospital link for cell and gene therapy

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? This alliance seeks to bolster clinical trial capabilities through improved regulatory processes and data governance. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Don’t let policy changes catch you off guard.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ultragenyx receives complete response letter for UX111 BLA

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

article thumbnail

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Give your business an edge with our leading industry insights.

article thumbnail

AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? AbbVie’s purchase comes just a few days after the US Food and Drug Administration (FDA) removed an access barrier for currently approved CAR-T therapies, regarded as a boost to the sector’s outlook. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

FDA removes safety programme for CAR-T therapies to boost uptake

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. This update also suggests we may not see REMS requirements for CD19 and BCMA autologous CAR-T cell therapies in the future,” the research note added.

article thumbnail

Some action points for the next PM

Express Pharma

Drug prices crash post-patent loss, due to this competition, which is good for patients but leaves drug makers struggling with thin profit margins. India’s traditional strength lies in small molecule chemical-based drugs which is why not too many companies focus on biologics.